Nationwide study Prisma: New hope for cancer patients in Regensburg!

Nationwide study Prisma: New hope for cancer patients in Regensburg!

Regensburg, Deutschland - The University of Regensburg has launched the nationwide Prisma study, which has set itself the goal of improving cancer patients. The study promoted by the national center for tumor diseases (NCT) is a randomized phase II study. It develops innovative care approaches, especially for rural regions. In the next four years, the study will be funded with more than two million euros. Renomed university clinics in Würzburg, Erlangen, Augsburg, Berlin and Cologne are involved

Prof. Dr. Anne Herrmann, who holds the scientific direction and a chair for medical sociology at the University of Regensburg, emphasizes that the study aims to optimize communication between medical staff, patients and relatives. By investigating the effectiveness of new approaches, the study would like to contribute to discharging the health system and provide knowledge that can be integrated into the oncological standard care.

key components of the study

• web-based micro learning modules: These short videos are intended to convey patients and relatives knowledge about diseases and therapies.
• Social prescriptions: Individual recommendations for non-medical support offers are created.
• digital feedback system: This system continuously records the health state of the patient in order to react early to individual needs.

Special attention applies to the situation of women with hormone -sensitive breast cancer who need additional treatment after surgery as well as chemotherapy and radiation therapy. Five to ten years of anti-hormone therapy can significantly reduce the risk of recurrence. However, 14 to 50 percent of these women break off daily medication within the first two years

.

In order to improve the compliance and quality of life of the patients, accompanying app applications are used. These apps contain a daily memory function for taking medication, and women are regularly asked about their psychosocial situation as well as side effects and loyalty to therapy. In the event of abnormalities, the responsible breast center is automatically notified, which means that the oncological nurse can contact the patient via (video) telephone to offer support. The chec-tum emphasizes the meaning of such approaches for the future of oncological care.

context and challenges in cancer supply

The 35th German Cancer Congress in Berlin in Berlin addressed the challenges of cancer supply in this context. Supply structures and research conditions were discussed under the motto "Interfaces between innovation and care". The parliamentary State Secretary Mario Brandenburg named funding areas for supply data -based research as part of the congress, which include the development of data integration centers at university clinics.

An important goal of the national strategies, such as the decade against cancer, is to make cancer curable or manageable in three out of four patients. The expansion of the national centrums for tumor diseases from two to six locations is sought. Nevertheless, Germany remains in global rankings under the study locations - from previously 6th place to a lower position. The reasons include a lack of harmonization in contracts and high regulatory challenges.

The need to improve the quality of the German healthcare system and the cooperation of all actors is more urgent than ever. In view of the decreasing clinical studies and the challenges for innovative medications such as in the AMNOG process, it is essential to take new ways in research and care, also to ensure future progress in cancer treatment, as reported in the knowledge of studies ( ncbi ).